New Delhi
Over 500 doctors and 150 nutritionists gathered at OBESITAS 2026, a major medical conference organised by the IJCP Group in association with the South Asian Obesity Forum, to address India’s rising obesity burden.
The event focused on obesity as a chronic, complex disease linked to diabetes, cardiovascular disorders, fatty liver disease, and hormonal imbalances. Experts stressed the need for early diagnosis, structured treatment, and multidisciplinary care to manage the growing public health crisis.
The conference, themed “Obesity Awareness, Advocacy, Action,” featured discussions on advanced therapies, including GLP-1 receptor agonists, dual incretin treatments, and medical nutrition therapy. Specialists also examined the increasing role of technology in obesity management and personalised treatment approaches.
Doctors noted that India is witnessing a sharp rise in obesity across both urban and rural populations, driven by sedentary lifestyles, dietary changes, and rising consumption of ultra-processed foods. This has led to a parallel increase in non-communicable diseases such as diabetes and heart disease.
A key highlight of the event was the national launch of the Thyroid Federation of India, aimed at improving awareness and coordinated care for metabolic disorders that often overlap with obesity.
Organisers said OBESITAS 2026 aimed to bridge gaps in clinical practice by bringing together endocrinologists, cardiologists, and nutrition experts on a single platform.
Health experts emphasised that obesity should no longer be seen as a lifestyle issue but as a serious medical condition requiring structured intervention and policy-level attention. The conference also called for stronger public health strategies and greater awareness to tackle India’s growing metabolic health crisis.